HealthQuill Evotec SE
Evotec SE has signed a technology pact with Novo Nordisk to produce cell therapy products for clinical development and commercial use, according to a company statement.
Drugs Health Pharma

Evotec SE in pact with Novo Nordisk to develop cell therapy products

Evotec SE has signed a technology pact with Novo Nordisk to produce cell therapy products for clinical development and commercial use, according to.

Read More
Evotec SE, a German drugmaker, announced its Seattle-based arm, has bagged a $74 million US government contract for the development of a monoclonal antibody-based product prototype to target orthopoxviruses.
Drugs Health Pharma

Germany’s Evotec wins $74 million US contract to make drug to fight orthopoxviruses

HQ Team July 5, 2023: Evotec SE, a German drugmaker, announced its Seattle-based arm, has bagged a $74 million US government contract for.

Read More